DOI QR코드

DOI QR Code

Clinical performance of FractionLab in patient-specific quality assurance for intensity-modulated radiotherapy : a retrospective study

  • Oh, Se An (Department of Radiation Oncology, Yeungnam University College of Medicine) ;
  • Kim, Sung Yeop (Department of Physics, Yeungnam University) ;
  • Park, Jaehyeon (Department of Radiation Oncology, Yeungnam University College of Medicine) ;
  • Park, Jae Won (Department of Radiation Oncology, Yeungnam University College of Medicine) ;
  • Yea, Ji Woon (Department of Radiation Oncology, Yeungnam University College of Medicine)
  • Received : 2021.05.12
  • Accepted : 2021.08.13
  • Published : 2022.04.30

Abstract

Background: This study was aimed at comparing and analyzing the results of FractionLab (Varian/Mobius Medical System) with those of portal dosimetry that uses an electronic portal imaging device. Portal dosimetry is extensively used for patient-specific quality assurance (QA) in intensity-modulated radiotherapy (IMRT). Methods: The study includes 29 patients who underwent IMRT on a Novalis-Tx linear accelerator (Varian Medical System and Brain-LAB) between June 2019 and March 2021. We analyzed the multileaf collimator DynaLog files generated after portal dosimetry to evaluate the same condition using FractionLab. The results of the recently launched FractionLab at various gamma indices (0.1%/0.1 mm-1%/1 mm) are analyzed and compared with those of portal dosimetry (3%/3 mm). Results: The average gamma passing rates of portal dosimetry (3%/3 mm) and FractionLab are 98.1% (95.5%-100%) and 97.5% (92.3%-99.7%) at 0.6%/0.6 mm, respectively. The results of portal dosimetry (3%/3 mm) are statistically comparable with the QA results of FractionLab (0.6%/0.6 mm-0.9%/0.9 mm). Conclusion: This paper presents the clinical performance of FractionLab by the comparison of the QA results of FractionLab using portal dosimetry with various gamma indexes when performing patient-specific QA in IMRT treatment. Further, the appropriate gamma index when performing patient-specific QA with FractionLab is provided.

Keywords

Acknowledgement

This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (No. 2021R1G1A1003209).

References

  1. Dai X, Zhao Y, Liang Z, Dassarath M, Wang L, Jin L, et al. Volumetric-modulated arc therapy for oropharyngeal carcinoma: a dosimetric and delivery efficiency comparison with static-field IMRT. Phys Med 2015;31:54-9. https://doi.org/10.1016/j.ejmp.2014.09.003
  2. Ali M, Babaiah M, Madhusudhan N, George G. Comparative dosimetric analysis of IMRT and VMAT (RapidArc) in brain, head and neck, breast and prostate malignancies. Int J Cancer Ther Oncol 2015;3:03019. https://doi.org/10.14319/ijcto.0301.9
  3. Mani KR, Upadhayay S, Das KJ. Influence of jaw tracking in intensity-modulated and volumetric-modulated arc radiotherapy for head and neck cancers: a dosimetric study. Radiat Oncol J 2017;35:90-100. https://doi.org/10.3857/roj.2016.02054
  4. Liu X, Huang E, Wang Y, He Y, Luo H, Zhong M, et al. Dosimetric comparison of helical tomotherapy, VMAT, fixed-field IMRT and 3D-conformal radiotherapy for stage I-II nasal natural killer T-cell lymphoma. Radiat Oncol 2017;12:76. https://doi.org/10.1186/s13014-017-0812-1
  5. Deng X, Han C, Chen S, Xie C, Yi J, Zhou Y, et al. Dosimetric benefits of intensity-modulated radiotherapy and volumetric-modulated arc therapy in the treatment of postoperative cervical cancer patients. J Appl Clin Med Phys 2017;18:25-31.
  6. Mellon EA, Javedan K, Strom TJ, Moros EG, Biagioli MC, Fernandez DC, et al. A dosimetric comparison of volumetric modulated arc therapy with step-and-shoot intensity modulated radiation therapy for prostate cancer. Pract Radiat Oncol 2015;5:11-5. https://doi.org/10.1016/j.prro.2014.03.003
  7. Oh SA, Yea JW, Park JW, Park J. Use of a head-tilting baseplate during volumetric-modulated arc therapy (VMAT) to better protect organs at risk in hippocampal sparing whole brain radiotherapy (HS-WBRT). PLoS One 2020;15:e0232430. https://doi.org/10.1371/journal.pone.0232430
  8. Oh SA, Kang MK, Kim SK, Yea JW. Comparison of IMRT and VMAT techniques in spine stereotactic radiosurgery with international spine radiosurgery consortium consensus guidelines. Prog Med Phys 2013;24:145-53. https://doi.org/10.14316/pmp.2013.24.3.145
  9. Huh SJ, Park W, Choi DH. Recent trends in intensity-modulated radiation therapy use in Korea. Radiat Oncol J 2019;37:249-53. https://doi.org/10.3857/roj.2019.00577
  10. Kim JI, Choi CH, Park SY, An H, Wu HG, Park JM. Gamma evaluation with portal dosimetry for volumetric modulated arc therapy and intensity-modulated radiation therapy. Prog Med Phys 2017;28:61-6. https://doi.org/10.14316/pmp.2017.28.2.61
  11. Yea JW, Park JW, Kim SK, Kim DY, Kim JG, Seo CY, et al. Feasibility of a 3D-printed anthropomorphic patient-specific head phantom for patient-specific quality assurance of intensity-modulated radiotherapy. PLoS One 2017;12:e0181560. https://doi.org/10.1371/journal.pone.0181560
  12. Ezzell GA, Burmeister JW, Dogan N, LoSasso TJ, Mechalakos JG, Mihailidis D, et al. IMRT commissioning: multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119. Med Phys 2009;36:5359-73. https://doi.org/10.1118/1.3238104
  13. Oh SA, Yea JW, Lee R, Park HB, Kim SK. Dosimetric verifications of the output factors in the small field less than 3 cm2 using the Gafchromic EBT2 films and the various detectors. Prog Med Phys 2014;25:218-24. https://doi.org/10.14316/pmp.2014.25.4.218
  14. Oh SA, Kang MK, Yea JW, Kim SH, Kim KH, Kim SK. Comparison of intensity modulated radiation therapy dose calculations with a PBC and AAA algorithms in the lung cancer. Korean J Med Phys 2012;23:48-53.
  15. Olaciregui-Ruiz I, Vivas-Maiques B, Kaas J, Perik T, Wittkamper F, Mijnheer B, et al. Transit and non-transit 3D EPID dosimetry versus detector arrays for patient specific QA. J Appl Clin Med Phys 2019;20:79-90. https://doi.org/10.1002/acm2.12610
  16. Han B, Ding A, Lu M, Xing L. Pixel response-based EPID dosimetry for patient specific QA. J Appl Clin Med Phys 2017;18:9-17.
  17. Defoor DL, Stathakis S, Roring JE, Kirby NA, Mavroidis P, Obeidat M, et al. Investigation of error detection capabilities of phantom, EPID and MLC log file based IMRT QA methods. J Appl Clin Med Phys 2017;18:172-9. https://doi.org/10.1002/acm2.12114
  18. Varian Medical Systems. DoseLab user guide - version 7.0 [Internet]. Houston, TX: Varian Medical Systems; 2018 [cited 2021 May 6]. https://www.myvarian.com/s/productdocumentation?lang=en.
  19. Kim YL, Chung JB, Kim JS, Lee JW, Choi KS. Comparison of the performance between portal dosimetry and a commercial two-dimensional array system on pretreatment quality assurance for volumetric-modulated arc and intensity-modulated radiation therapy. J Korean Phys Soc 2014;64:1207-12. https://doi.org/10.3938/jkps.64.1207
  20. Krishna Murthy K. Patient-specific quality assurance of RapidArc treatments: portal prediction dosimetry compared with phantom studies. Biomed Imaging Interv J 2012;8:e28.
  21. Stanhope CW, Drake DG, Liang J, Alber M, Sohn M, Habib C, et al. Evaluation of machine log files/MC-based treatment planning and delivery QA as compared to ArcCHECK QA. Med Phys 2018;45:2864-74. https://doi.org/10.1002/mp.12926